Datatrak partners with Stat Research

Tuesday, May 14, 2013 01:24 PM

Datatrak International, a developer of cloud-based, unified eClinical technologies and related services, has partnered with Stat Research, a medically-driven CRO based in Argentina that provides research services in Latin America.

“In the context of a rapidly expanding clinical trial field in the early 2000s, we saw the opportunity to develop a company to become leaders based on our previous research expertise developed over many years in the U.S.,” said Stat Research CEO Dr. Conrado J. Estol. “Our initial focus on CNS soon spanned into many other medical specialties and our group grew solid by incorporating some of the people with most clinical trial experience in the region. Our recent partnership with Datatrak will add the necessary tools to achieve much more effective and efficient results in an increasingly complex and time-sensitive research environment.”

“Our partnership with STAT Research combines the Datatrak One technology with local industry experts,” said Laurence P. Birch, Datatrak’s chairman and CEO.

The Datatrak Connect Partner Program is collaboration between synergic companies to accelerate the drug development process. The program allows for extended service offerings to cover all areas of the drug development process to reduce study costs and further business development objectives. Datatrak has offices in Cleveland, Ohio; Bryan, Texas; and Cary, N.C.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs